Civitas Resources, Inc. (NYSE:CIVI) Q1 2025 Earnings Conference Call May 8, 2025 8:30 AM ET Company Participants Brad Whitmarsh – Head, Investor Relations Chris...
This article was written by Follow Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish...
This article was written by Follow Fidelity’s mission is to strengthen the financial well-being of our customers and deliver better outcomes for the clients...
Investment thesis Our current investment thesis is: JHG has struggled with growth, as investors are increasingly unconvinced by the value offered by active management....
Introduction ImmunoGen (NASDAQ:IMGN) is a commercial-stage biotech firm focused on developing innovative antibody-drug conjugates (ADCs) to enhance cancer treatment. These targeted therapies boast improved...
Intro Churchill Downs Incorporated (NASDAQ:CHDN) is a prominent entertainment company in the United States that operates in the racing, online wagering, and gaming sectors....
The Food and Drug Administration (FDA) has granted final approval to the anti-Alzheimer’s drug lecanamab, marked as Leqembi by drugmakers Eisai and Biogen BIIB...